Q3 2026 13F filing
Updated 6 days ago92 disclosed positions worth $10B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A ASCENDIS PHARMA A/S | $2.3B | 10.28M | 23.50% | — |
| 2 | P PARABILIS MEDICINES INC | $942.2M | 29.18M | 9.45% | — |
| 3 | P VAXCYTE INC | $652.9M | 11.47M | 6.55% | — |
| 4 | R RHYTHM PHARMACEUTICALS INC | $634.8M | 6.67M | 6.37% | — |
| 5 | E EDGEWISE THERAPEUTICS INC | $340.7M | 8.39M | 3.42% | — |
| 6 | T TYRA BIOSCIENCES INC | $266.8M | 12.20M | 2.68% | — |
| 7 | F FREENOME INC | $242M | 15.37M | 2.43% | — |
| 8 | C HEMAB THERAPEUTICS HOLDINGS | $240.8M | 7.81M | 2.42% | — |
| 9 | N NEWAMSTERDAM PHARMA CO NV | $232.3M | 9.55M | 2.33% | — |
| 10 | S SEPTERNA INC | $215.3M | 5.50M | 2.16% | — |
| 11 | S SPYGLASS PHARMA INC | $208.5M | 8.02M | 2.09% | — |
| 12 | J JANUX THERAPEUTICS INC | $193.4M | 11.19M | 1.94% | — |
| 13 | M MINERALYS THERAPEUTICS INC | $193.3M | 7.69M | 1.94% | — |
| 14 | I DISC MEDICINE INC | $160.4M | 2.45M | 1.61% | — |
| 15 | T TAYSHA GENE THERAPIES INC | $148.2M | 30.44M | 1.49% | — |
| 16 | B BICARA THERAPEUTICS INC | $135M | 7.26M | 1.35% | — |
| 17 | A ARTIVA BIOTHERAPEUTICS INC | $131.6M | 18.49M | 1.32% | — |
| 18 | X XENCOR INC | $131.6M | 5.27M | 1.32% | — |
| 19 | O ORUKA THERAPEUTICS INC | $129.5M | 1.55M | 1.30% | — |
| 20 | A AMYLYX PHARMACEUTICALS INC | $124.5M | 4.28M | 1.25% | — |
| 21 | ? N/A CLIMB BIO INC | $116.2M | 10.13M | 1.17% | — |
| 22 | A ABIVAX SA-ADR | $102M | 1.03M | 1.02% | — |
| 23 | W WAVE LIFE SCIENCES INC | $99.8M | 26.98M | 1.00% | — |
| 24 | ? N/A LATIGO BIOTHERAPEUTICS INC | $88.6M | 5.30M | 0.89% | — |
| 25 | S SOLID BIOSCIENCES INC | $87M | 12.04M | 0.87% | — |
| 26 | V VOR BIOPHARMA INC | $85.9M | 4.50M | 0.86% | — |
| 27 | L LB PHARMACEUTICALS INC | $84.8M | 2.21M | 0.85% | — |
| 28 | G GH RESEARCH PLC | $84.7M | 3.61M | 0.85% | — |
| 29 | O OBSIDIAN THERAPEUTICS INC | $81.8M | 5.96M | 0.82% | — |
| 30 | Z ZAI LAB LTD-ADR | $74.2M | 2.82M | 0.74% | — |
| 31 | F 4D MOLECULAR THERAPEUTICS IN | $72.3M | 5.05M | 0.72% | — |
| 32 | A ACLARIS THERAPEUTICS INC | $66.9M | 12.72M | 0.67% | — |
| 33 | S SANA BIOTECHNOLOGY INC | $54.7M | 18.75M | 0.55% | — |
| 34 | M MONOPAR THERAPEUTICS INC | $53.2M | 667.2K | 0.53% | — |
| 35 | G GERON CORP | $52.6M | 42.75M | 0.53% | — |
| 36 | ? N/A DAMORA THERAPEUTICS INC | $51.1M | 2.40M | 0.51% | — |
| 37 | P PEPGEN INC | $48.6M | 20.06M | 0.49% | — |
| 38 | S ARS PHARMACEUTICALS INC | $46.8M | 10.86M | 0.47% | — |
| 39 | ? N/A ACUMEN PHARMACEUTICALS INC | $46.6M | 20.99M | 0.47% | — |
| 40 | D DBV TECHNOLOGIES SA-SPON ADR | $43M | 3.66M | 0.43% | — |
| 41 | A AGENUS INC | $40.9M | 4.12M | 0.41% | — |
| 42 | R REZOLUTE INC | $39.1M | 9.45M | 0.39% | — |
| 43 | S SIONNA THERAPEUTICS INC | $34M | 6.46M | 0.34% | — |
| 44 | ? N/A SCRIBE THERAPEUTICS INC | $33.2M | 1.80M | 0.33% | — |
| 45 | C CENTURY THERAPEUTICS INC | $30.4M | 17.75M | 0.30% | — |
| 46 | E EVOMMUNE INC | $28.9M | 3.49M | 0.29% | — |
| 47 | K KORSANA BIOSCIENCES INC | $28.6M | 892.7K | 0.29% | — |
| 48 | C CAPRICOR THERAPEUTICS INC | $28.5M | 3.01M | 0.29% | — |
| 49 | N NKARTA INC | $28.3M | 10.81M | 0.28% | — |
| 50 | B C4 THERAPEUTICS INC | $27.3M | 8.19M | 0.27% | — |